Cargando…
Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics
Central nervous system drug discovery and development is hindered by the impermeable nature of the blood–brain barrier. Pharmacokinetic modeling can provide a novel approach to estimate CNS drug exposure; however, existing models do not predict temporal drug concentrations in distinct brain regions....
Autores principales: | Zakaria, Zaril, Badhan, Raj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874827/ https://www.ncbi.nlm.nih.gov/pubmed/29342085 http://dx.doi.org/10.3390/pharmaceutics10010014 |
Ejemplares similares
-
Clopidogrel Pharmacokinetics in Malaysian Population Groups: The Impact of Inter-Ethnic Variability
por: Zakaria, Zaril H., et al.
Publicado: (2018) -
Development of a Physiologically-Based Pharmacokinetic Model of the Rat Central Nervous System
por: Badhan, Raj K. Singh, et al.
Publicado: (2014) -
Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability
por: Dennison, Thomas J, et al.
Publicado: (2017) -
Optimising Fluvoxamine Maternal/Fetal Exposure during Gestation: A Pharmacokinetic Virtual Clinical Trials Study
por: Burhanuddin, Khairulanwar, et al.
Publicado: (2022) -
Application of Pharmacokinetics Modelling to Predict Human Exposure of a Cationic Liposomal Subunit Antigen Vaccine System
por: Badhan, Raj K. S., et al.
Publicado: (2017)